SAFEGUARD SCIENTIFICS INC (SFES)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
05.01.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECr will make a market in the common stock.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
18.12.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECorated into this Item 3.01 by reference.   Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
05.10.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECaction.         Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Offi

Stammdaten

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Unternehmen & Branche

NameSAFEGUARD SCIENTIFICS INC
TickerSFES
CIK0000086115
BoerseUS
SektorFinancial Services
IndustrieAsset Management
SIC6799 · Investors, NEC

Wertpapier & Kennzahlen

CUSIP786449207
ISINUS7864492076
TypCommon Stock
Marktkapitalisierung8,2 Mio. USD
Beta-0,47
Dividendenrendite1,40 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2011-12-3110-K110,597,000
2009-12-3110-K34,839,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
HUNTINGTON NATIONAL BANK1011Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
HUNTINGTON NATIONAL BANK11100.00

Hinweis

Erweitert ×